What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.40%Below 5Y avg (2.55%)
Annual Rate
JPY 58.00Paid semi-annual
Payout Ratio
53.9%Sustainable
Next Ex-Dividend
Mar 30, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
81.70BJPY
511.49M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
22.42x
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
42.43BJPY
265.65M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
8.37%
vs Medical Devices peers
Updated Oct 21, 2026
Beta
0.3220x
vs all stocks
Updated Oct 21, 2026
52-Week Change
1.43%
vs all stocks
Updated Oct 21, 2026
Forward Annual Dividend Yield
2.40%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
81.70BJPY
511.49M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
77.97BJPY
488.18M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
22.42x
vs Medical Devices peers
Updated Oct 21, 2026
Forward P/E
26.38x
vs Medical Devices peers
Updated Oct 21, 2026
Price to Sales (TTM)
1.87x
vs Medical Devices peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.93×.Updated Oct 21, 2026
Price to Book (MRQ)
1.83x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to Revenue
1.84x
vs Medical Devices peers
Updated Oct 21, 2026
Enterprise to EBITDA
14.48x
vs Medical Devices peers
Updated Oct 21, 2026
Profit Margin
8.37%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Margin
6.23%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Assets (TTM)
2.87%
vs Medical Devices peers
Updated Oct 21, 2026
Return on Equity (TTM)
8.34%
vs Medical Devices peers
Updated Oct 21, 2026
Revenue (TTM)
42.43BJPY
265.65M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
1.29KJPYUpdated Oct 21, 2026
Quarterly Revenue Growth
5.20%
vs Medical Devices peers
Updated Oct 21, 2026
Gross Profit (TTM)
16.15BJPY
101.12M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
5.41BJPY
33.87M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
3.55BJPY
22.24M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-25.80%
vs Medical Devices peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
4.04BJPY
25.33M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
3.71BJPY
23.22M · vs all stocks (USD)
Updated Oct 21, 2026
Forward Annual Dividend Rate
58.00JPYUpdated Oct 21, 2026
Forward Annual Dividend Yield
2.40%
vs all stocks
Updated Oct 21, 2026
Trailing Annual Dividend Rate
58.00JPYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
2.40%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
2.55%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
53.94%
vs Medical Devices peers
Updated Oct 21, 2026
Revenue
41.90BJPYFY2026 · Mar 31, 2026
Cost of Goods Sold
25.72BJPYFY2026 · Mar 31, 2026
Gross Profit
16.18BJPYFY2026 · Mar 31, 2026
Operating Income
2.92BJPY
18.28M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
4.83BJPYFY2026 · Mar 31, 2026
Income Tax Expense
1.13BJPYFY2026 · Mar 31, 2026
Net Income
3.71BJPYFY2026 · Mar 31, 2026
EBIT
4.86BJPYFY2026 · Mar 31, 2026
EBITDA (Income Statement)
5.41BJPYFY2026 · Mar 31, 2026
Non-operating Interest Income
17.00MJPYFY2026 · Mar 31, 2026
Non-operating Interest Expense
29.00MJPYFY2026 · Mar 31, 2026
EPS (Basic)
112.52JPYFY2026 · Mar 31, 2026
EPS (Diluted)
112.08JPYFY2026 · Mar 31, 2026
Basic Shares Outstanding
32.96MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
32.96MSharesFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026
Operating Cash Flow
5.19BJPYFY2026 · Mar 31, 2026
Free Cash Flow
-674.00MJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
7.94BJPYFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
4.83BJPYFY2026 · Mar 31, 2026
Other Non-cash Items
-7.00MJPYFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
341.00MJPYFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
26.00MJPYFY2026 · Mar 31, 2026
Capital Expenditures
-5.87BJPYFY2026 · Mar 31, 2026
Net Intangibles (CF)
-90.00MJPYFY2026 · Mar 31, 2026
Net Acquisitions
2.07BJPYFY2026 · Mar 31, 2026
Purchase of Investments
-1.58BJPYFY2026 · Mar 31, 2026
Sale of Investments
2.24BJPYFY2026 · Mar 31, 2026
Other Investing Activity
-201.00MJPYFY2026 · Mar 31, 2026
Net Investing Cash Flow
-3.33BJPYFY2026 · Mar 31, 2026
Long-term Debt Issuance
3.00BJPYFY2026 · Mar 31, 2026
Long-term Debt Payments
-50.00MJPYFY2026 · Mar 31, 2026
Common Stock Repurchase
-1.68BJPYFY2026 · Mar 31, 2026
Common Dividends Paid
-1.86BJPYFY2026 · Mar 31, 2026
Other Financing Charges
261.00MJPYFY2026 · Mar 31, 2026
Net Financing Cash Flow
-322.00MJPYFY2026 · Mar 31, 2026
Shares Outstanding
32.97MSharesUpdated Oct 21, 2026
Float Shares
26.73MSharesUpdated Oct 21, 2026
% Held by Insiders
3.72%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
60.89%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
9.89BJPY
61.91M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
299.95JPYUpdated Oct 21, 2026
Total Debt (MRQ)
5.87BJPY
36.78M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.1351x
vs Medical Devices peers
Updated Oct 21, 2026
Current Ratio (MRQ)
2.20x
vs Medical Devices peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
1.32KJPYUpdated Oct 21, 2026
Total Assets
62.65BJPY
392.26M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
32.04BJPYFY2026 · Mar 31, 2026
Total Liabilities
18.62BJPYFY2026 · Mar 31, 2026
Total Non-current Assets
30.61BJPYFY2026 · Mar 31, 2026
Total Non-current Liabilities
3.99BJPYFY2026 · Mar 31, 2026
Total Current Liabilities
14.64BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents
10.94BJPYFY2026 · Mar 31, 2026
Other Short-term Investments
354.00MJPYFY2026 · Mar 31, 2026
Accounts Receivable
10.17BJPYFY2026 · Mar 31, 2026
Inventory
7.99BJPYFY2026 · Mar 31, 2026
Accounts Payable
4.84BJPYFY2026 · Mar 31, 2026
Short-term Debt
3.71BJPYFY2026 · Mar 31, 2026
Other Current Liabilities
4.69BJPYFY2026 · Mar 31, 2026
Long-term Debt
3.58BJPYFY2026 · Mar 31, 2026
Other Non-current Liabilities
343.00MJPYFY2026 · Mar 31, 2026
Common Stock (Book)
6.90BJPYFY2026 · Mar 31, 2026
Retained Earnings
30.88BJPYFY2026 · Mar 31, 2026
Total Shareholders' Equity
44.03BJPY
275.69M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Treasury Stock
2.24BJPYFY2026 · Mar 31, 2026
52-Week Low
2.02KJPYUpdated Oct 21, 2026
52-Week High
3.50KJPYUpdated Oct 21, 2026
52-Week Change
1.43%
vs all stocks
Updated Oct 21, 2026
Beta
0.3220x
vs all stocks
Updated Oct 21, 2026
50-Day MA
2.33KJPYUpdated Oct 21, 2026
200-Day MA
2.66KJPYUpdated Oct 21, 2026
Avg 10-Day Volume
196.62KSharesUpdated Oct 21, 2026
Avg 30-Day Volume
154.85KSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
107.53JPYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.